Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov 17:9:e45266.
doi: 10.2196/45266.

National Initiatives on Salt Substitutes: Scoping Review

Bingxuan Kong  1   2 , Shanyue Yang  2 , Jiewei Long  2 , Yuhan Tang  2 , Yang Liu  1 , Zeng Ge  3 , Shuang Rong  4 , Yangfeng Wu  5 , Gangqiang Ding  1   6 , Yuexin Yang  1   7 , Ping Yao #  2   8 , Chao Gao #  1   6
Affiliations

National Initiatives on Salt Substitutes: Scoping Review

Bingxuan Kong et al. JMIR Public Health Surveill. .

Abstract

Background: Salt substitutes are edible salts that contain less sodium chloride owing to its partial substitution with other minerals, which serve as an important and effective intervention and public health strategy targeting hypertension and its secondary diseases, despite a small degree of controversy.

Objective: This study aimed to identify the current salt substitute initiatives in various nations and intergovernmental organizations (IGOs) worldwide and summarize their types and characteristics.

Methods: A scoping review was performed based on Arksey and O'Malley's framework and the latest guidance from the Joanna Briggs Institute. Searches were conducted on Google; government websites on food, health, and other related topics; PubMed; Web of Science; and Google Scholar from January 2022 to May 2022. Initiatives related to salt substitutes that were included in the study focused on the involvement of governments or IGOs through the publication of standards, actions, collaborations, funding, and so on. Data were extracted into Microsoft Excel (version 2019; Microsoft Corp) based on predefined items and analyzed using narrative synthesis and frequency count methods.

Results: A total of 35 initiatives from 11 countries (of which 9 are high-income countries) and 3 IGOs were identified. We classified all salt substitute initiatives into 5 types, namely benefit-risk assessments and cautions; plans and actions; regulations and standards; labels; and food reformulation, cooperation with the food industry, and media. More than half (18/35, 51%) of the salt substitute initiatives were launched within the past 5 years. Except for regulations and standards, salt substitute initiatives are, in general, part of the salt reduction framework. No nation or IGO has yet reported on the monitoring and implications of the use of salt substitutes.

Conclusions: Despite the limited number of salt substitute initiatives worldwide at present, a review on the different types and characteristics of such initiatives could be helpful in providing a reference for policy makers and stakeholders. Given the great potential of salt substitutes in improving hypertension and stroke, we call on more nations to pay attention to these substitutes and propose salt substitute initiatives in line with their national conditions.

Keywords: initiatives; nutrition policy; salt substitute; strategies.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: None declared.

Figures

Figure 1
Figure 1
Flow diagram of salt substitute initiatives identification. IGO: intergovernmental organization.
Figure 2
Figure 2
National salt substitute initiatives.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. GBD 2019 Risk Factors Collaborators Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020 Oct 17;396(10258):1223–49. doi: 10.1016/S0140-6736(20)30752-2. https://air.unimi.it/handle/2434/776344 S0140-6736(20)30752-2 - DOI - PMC - PubMed
    1. Du Y, Zhou N, Zha W, Lv Y. Hypertension is a clinically important risk factor for critical illness and mortality in COVID-19: a meta-analysis. Nutr Metab Cardiovasc Dis. 2021 Mar 10;31(3):745–55. doi: 10.1016/j.numecd.2020.12.009. https://europepmc.org/abstract/MED/33549450 S0939-4753(20)30518-4 - DOI - PMC - PubMed
    1. Omboni S, McManus RJ, Bosworth HB, Chappell LC, Green BB, Kario K, Logan AG, Magid DJ, Mckinstry B, Margolis KL, Parati G, Wakefield BJ. Evidence and recommendations on the use of telemedicine for the management of arterial hypertension: an international expert position paper. Hypertension. 2020 Nov;76(5):1368–83. doi: 10.1161/HYPERTENSIONAHA.120.15873. - DOI - PubMed
    1. Zhou M, Wang H, Zeng X, Yin P, Zhu J, Chen W, Li X, Wang L, Wang L, Liu Y, Liu J, Zhang M, Qi J, Yu S, Afshin A, Gakidou E, Glenn S, Krish VS, Miller-Petrie MK, Mountjoy-Venning WC, Mullany EC, Redford SB, Liu H, Naghavi M, Hay SI, Wang L, Murray CJ, Liang X. Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2019 Sep 28;394(10204):1145–58. doi: 10.1016/S0140-6736(19)30427-1. https://linkinghub.elsevier.com/retrieve/pii/S0140-6736(19)30427-1 S0140-6736(19)30427-1 - DOI - PMC - PubMed
    1. Global action plan for the prevention and control of NCDs 2013–2020. World Health Organization. 2013. Nov 14, [2022-05-05]. https://www.who.int/publications/i/item/9789241506236 .

Publication types

Substances